The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Cleveland BioLabs, Inc(NASDAQ:CBLI) 
Cleveland BioLabs, Inc., a biopharmaceutical company, develops novel approaches to activate the immune system and address various medical needs in the United States and Russia. Its proprietary platform of toll-like immune receptor activators (TLR) has applications in mitigation of radiation injury, ...
Website: http://www.cbiolabs.com
Full Time Employees: 2 (May 2021)
Sector: Healthcare
Industry: Biotechnology
Cleveland BioLabs Days Receivable Outstanding ttm (DSO)
Cleveland BioLabs Op Cashflow Per Share ttm
Cleveland BioLabs Free Cashflow Per Share ttm
Cleveland BioLabs Cash Per Share ttm
Cleveland BioLabs P/S ratio ttm
Cleveland BioLabs (GAAP) P/E ratio ttm
Cleveland BioLabs P/B ratio ttm
No extra charts and metrics for this ticker.